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A B S T R A C T
Aim: Here, we evaluate the ddPCR platform using an evaluated qPCR-based diagnostic assay for the
detection of Leishmania infection in Cutaneous Leishmaniasis patients.
Methods: A standard curve of cultured Leishmania parasite material and clinical samples of CL patients
were tested with ddPCR to determine the analytical and diagnostic performance.
Results: The limit of detection of the assay on the ddPCR platform was much higher than the published
limit of detection of the same assay on the qPCR platform (100 vs 1 parasites/mL, respectively).
Conclusion: While the performance of this assay in ddPCR format was acceptable for research purposes, it
is not sufﬁcient for clinical diagnostic purposes. The assay is more suited to the qPCR platform.
© 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Cutaneous leishmaniasis (CL) caused by Leishmania species is
characterized by the presence of ulcerative lesions leading to
disﬁguring and/or incapacitating scars (Akhoundi et al., 2017;
Desjeux, 2001; Alvar et al., 2012; Jara et al., 2013). Traditionally,
microscopic examination is considered the diagnostic routine
method for CL. However, its sensitivity is low and molecular
methods have shown increased sensitivity. Recently, our group
reported the ﬁrst analytical validation of the L18S target using PCR,
qPCR and LAMP platforms for New World Leishmania species (León
et al., 2017, 2018). Different authors have also conducted this across
Latin America (Moreira et al., 2018). Droplet digital PCR (ddPCR)
enables the absolute quantitation of nucleic acids in a sample and
has subsequently been applied to detect DNA of pathogens.
Therefore, the aim of this work was to develop and test a ddPCR
assay and compare its results with those obtained by the
previously analytically validated qPCR assay.
L. braziliensis, L. panamensis, L. major, L. donovani, L. infantum, L.
guyanensis and L. mexicana were used to construct Standard curves
diluting each parasite culture eluate in ten-fold dilution steps from
105–102 parasites/mL. For ddPCR, a new dual-labelled probe was
designed using Primer Express 3 software (L18SPr 50-[6FAM] AGT
TCG GGG GAG AAC GTA CT [BHQ1]-30), and checked using AmpliFx.
An endogenous control assay (Homo sapiens ribonuclease P/MRP
subunit p30 [HsRPP30]) was described by Luo et al., (2005). The
L18S primers were previously reported in León et al. (2017)
The L. braziliensis standard curve was repeat tested ﬁve times
within-plate and on ﬁve different plates to assess the technical
performance of the assay. The analytical limit of detection
was determined as the concentration of the lowest step of this
series at which all 10 replicates tested positive. In order to test
the diagnostic performance of ddPCR, 138 samples previously
diagnosed as positive by microscopy and qPCR and 83 samples
that were negative by microscopy and qPCR were tested with
ddPCR.
During repeat testing of the L. braziliensis standard curve, the
lower limit of detection was 100 parasites/mL (6 copies/mL by
ddPCR). The Pearson Correlation Coefﬁcient between L18S copies/
mL (ddPCR) and parasites/mL (qPCR) in the dilution steps where all
* Corresponding author.
E-mail address: juand.ramirez@urosario.edu.co (J.D. Ramírez).
1 Both authors contributed equally.
https://doi.org/10.1016/j.ijid.2018.10.029
1201-9712/© 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
International Journal of Infectious Diseases 79 (2019) 1–3
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journal home page: www.elsevier .com/ locat e/ i j id
repeat tests were detected was 0.983 and the efﬁciency of the assay
was 106% (Figure 1A). Upon testing of a number of different
Leishmania species, the L18S assay detected all the different species
tested (Figure 1B). The mean between-plate coefﬁcient of variance
(CV) across the whole series was 17.8%, and the CV at 100 parasites/
mL is much higher than at 100,000 parasites/mL (47.2 compared to
3.6%). The mean within-plate CV was 30.0%, and the CV did not vary
very much throughout the curve (range: 27.7–32.6%). The total
coefﬁcient of variance across both of these sources of variation was
53.6%. Finally, the ddPCR CV is not signiﬁcantly different to the CV
of qPCR at either the lowest concentration of the dilution series
(100 parasites/mL qPCR CV = 28.8% versus ddPCR CV = 27.7%) but
was higher than the qPCR CV at the highest concentration of the
series (100,000 parasites/mL qPCR CV = 17.4% versus ddPCR CV =
31.3%; Figure 1C).
The ROC plot for the comparison of diagnostic performance at
different zeta values is displayed in Figure 1D. A zeta value of 0.85–
0.90 resulted in the highest area under the curve in the ROC
analysis (0.832), and at that level the optimised sensitivity and
speciﬁcity of ddPCR compared to qPCR were 84 and 85%,
respectively. However, given there are a number of other causes
of skin lesions in tropical settings, we decided speciﬁcity >90%
should be prioritized. We therefore considered a zeta value of 0.95
(95% probability of non-zero load) to be optimal for this test. The
area under the curve at that level was 0.822.
In conclusion, we report the ﬁrst evaluation of the suitability of
a ddPCR platform to detect Leishmania DNA in specimens obtained
from patients with CL. The technical and clinical performance of
the ddPCR assay evaluated here does not support its routine usage
over qPCR, mainly due to its lack of sensitivity and speciﬁcity. In
addition, ddPCR is three times more expensive than qPCR and not
suitable as a routine diagnostic test. However, ddPCR shows several
advantages as quantitation of DNA without the need for calibration
curves and therefore exact and reference values could be obtained
per sample (higher-order reference measurement method) as has
been suggested for various viral diseases (Hayden et al., 2013;
Rutsaert et al., 2018). The platform may also to be evaluated with
other oligonucleotide assays to further investigate its potential for
the molecular diagnosis of CL.
Acknowledgements
We thank Lissa Cruz-Saavedra from Universidad del Rosario for
providing DNA of the Leishmania species.
Conﬂict of interest
None.
Funding source
Funding was provided by DIRECCION DE INVESTIGACION E
INNOVACION from Universidad del Rosario. JDR received a grant
“Estancias Cortas de Investigación” from DIRECCION ACADEMICA
from UNIVERSIDAD DEL ROSARIO.
Ethical approval
The study protocol was approved by the Technical Research
Committee and Ethics Research Board at the National Health
Institute in Bogotá, Colombia, protocol CTIN-023-17 in the
framework of the project “FORTALECIMIENTO Y VIGILANCIA DE
LA CAPACIDAD DIAGNOSTICO DE ENFERMEDADES EMERGENTES Y
REEMERGENTES EN COLOMBIA”. Participation (Only adults) was
voluntary and patients were asked for informed written consent.
The diagnostic evaluation protocol was additionally approved by
the London School of Hygiene & Tropical Medicine Observational
Ethics Committee (protocol number 15515).
Figure 1. A. Serial ten-fold dilution of L.braziliensis repeat tested with L18S assay on ddPCR platform. B. Serial ten-fold dilution of several Leishmania species on ddPCR
platform. C. Within-plate variance of L18S assay run on qPCR and ddPCR platforms across a range of parasite loads. D. ROC curve results compating ddPCR vs. qPCR.
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